Summary of CK2α mutantsa
1. Introduction
Protein kinases constitute one of the largest and best-explored superfamilies of mammalian genes. The human genome encodes approximately 518 protein kinase genes, and the majority of their proteins have been characterized to some extent. Many of protein kinases have been implicated in signal transduction pathways that regulate growth and survival of cells, indicating their potential role in cancer (Manning et al., 2002a). Indeed, most cancers are associated with disregulation of protein kinases or by loss or damage of cellular protein kinase inhibitors (Brognard & Hunter, 2011; Johnson, 2009; Pearson & Fabbro, 2004).
A typical protein kinase (based on 478 known enzymes) is characterized by the presence of a highly homologous kinase catalytic domain of about 300 amino acid residues. This domain serves three distinct roles: (a) binding and orientation of the phosphate donor (ATP or, rarely, a different nucleoside triphosphate) in a complex with a divalent cation (usually Mg2+ or Mn2+); (b) binding and orientation of the protein substrate; and (c) transfer of the γ-phosphate from the NTP to the hydroxyl moiety of the acceptor residue of the protein substrate.
In response to a variety of regulatory signals, protein kinases phosphorylate specific serine, threonine, or tyrosine residues within target proteins to modify their biological activities. Phosphorylation of several proteins in the cell creates recognition and/or regulatory sites that influence many properties of the target proteins (
The first 3D structure of a protein kinase was determined for PKA by X-ray crystallography. It revealed the basic bi-lobed scaffold formed by N- and C-terminal lobes that has been observed in all the protein kinase structures solved to date. The N-terminal lobe of the kinase fold comprises of an anti-parallel β-sheet made of five β-strands (β1 – β5) and a single αC-helix. The C-terminal lobe is larger and is mainly composed of α-helices. The nucleotide- and substrate-binding pockets are located in the cleft between the two lobes. The phosphate groups of ATP are positioned for phosphotransfer by their interactions with conserved residues in the N- and C-terminal lobes. These include a glycine-rich loop characterized by the GXGXXG motif (where X represents any amino acid) between the β1 and β2 strands, a Lys residue localized by a salt bridge formed by a Lys-Glu pair (K72 and E91), and Mg2+ ions. The conserved Asn (N171) and Asp (D184) further coordinate the metal ions. The catalytic loop situated in the C-terminal lobe contains aspartate (D166), referred to as the catalytic base that facilitates extraction of a proton from the hydroxyl side-chains of the phospho-sites of the substrates. The activation segment (20–30 residues in length) caps the C-terminal lobe. This segment forms a part of the substrate-binding pocket and shows high structural variation in the active and inactive kinase structures.
The grouping of the protein kinases based on catalytic subunit sequence similarity results in clustering of kinases that share functional features, such as preferred sites of phosphorylation, the mode of regulation and cellular localization. The similarity in the amino acid sequence of the catalytic domains of protein kinases has proven to be a good indicator of other features held in common by the different members of the family.
The diversity of essential functions mediated by kinases is shown by the conservation of approximately 50 distinct kinase families that have been identified in yeast, invertebrates, and mammals. Protein kinases can be clustered into groups, families, and sub-families. These classifications are based on sequence similarity and biochemical function. Among the 518 human protein kinases, 478 belong to a single superfamily whose catalytic domains are related in sequence.
Protein kinases are divided into 10 main groups, which organize diversity and compare genes between distant organisms (Miranda-Saavedra & Barton, 2007). The groups are named as follows: AGC, CAMK, CK1, CMGC, STE, RGC, Other, TK, TK, and Atypical. This classification was first used for characterization of the human kinome (all the kinases encoded in the genome) (Manning et al., 2002) and is based on an earlier classification by Hanks and Hunter (1995).
1.1. The CMGC kinases
This group of Ser/Thr protein kinases was named after the initials of some members (CDK, MAPK, GSK3, and CLK). It includes key kinases involved in growth, stress-response, and the cell cycle, and kinases involved in splicing and metabolic control. The four well characterized subfamilies of this group include the following: cyclin-dependent kinases (CDK) (Liolli, 2010); mitogen-activated protein kinases (MAPK) (Biondi & Nebreda, 2003; Zhang & Dong, 2007); glycogen synthase kinases (GSK) (Biondi & Nebreda, 2003); and cell kinases 2 (CK2), better known as protein kinase CK2 or casein kinase 2 (St-Denis & Litchfield, 2009). The CMGC group also contains other members. These are the following: SR protein kinases [phosphorylating serine- and arginine-rich proteins engaged in regulation of splicing and nuclear transport (Ghosh & Adams, 2011)] and DYRK protein kinases,
1.2. Protein kinase CK2
Protein kinase CK2, formerly called casein kinase II, is a ubiquitous second messenger-independent protein kinase found in all eukaryotic organisms examined (Jensen et al., 2007; Niefind et al., 2009; Litchfield, 2003, Kubiński et al., 2007). This enzyme, which has been studied for over 50 years, is able to phosphorylate more than 300 substrates, on serine, threonine and tyrosine (Meggio & Pinna, 2003; Vilk et al., 2008). As the list of targets for CK2 continues to grow, it is becoming evident that CK2 has the potential to participate in the regulation of various cellular processes. Most of the CK2 substrates reported so far correspond to proteins that participate in cell signaling (Ahmed et al., 2002; Meggio & Pinna, 2003).
Protein kinase CK2 is distributed ubiquitously in eukaryotic organisms, where it appears as a tetrameric complex composed of two catalytic subunits (α/α’) associated with a dimer of regulatory β subunits (Figs. 1 & 2). The CK2 tetramer exhibits constitutive activity that can be easily detected in most cellular or tissue extracts in the absence of any stimulatory compounds. In many organisms, distinct isoenzymic forms of the catalytic subunit of CK2 have been identified (Glover, 1998; Kolaiti et al., 2011; Kouyanou-Koutsoukou et al., 2011a, b; Maridor et al., 1991; Litchfield et al., 1990; Shi et al., 2001). In humans, only a single regulatory CK2β subunit has been identified; but multiple forms of CK2β have been identified in other organisms, such as
The catalytic subunits of CK2α and CK2α’ are the products of separate genes located in different chromosomes. The 330 N-terminal amino acids exhibit over 90% sequence identity. However, the C-terminal sequences are unrelated (Olsten & Litchfield, 2004). The unique C-terminal domains of the catalytic subunits are highly conserved among species (
Although there is no known difference between the catalytic activities of CK2α and CK2α’, there is evidence that they exhibit functional specialization (Duncan & Lichfield, 2008; Faust & Montenarch, 2000). The CK2α subunit is phosphorylated at C-terminal sites (Thr344, Thr360, Ser362 and Ser360) by p34cdc2 during cell cycle progression, while CK2α’ is not phosphorylated (St-Denis et al., 2009). Further evidence to support the idea that CK2α and CK2α’ have independent functions in the cell is provided by the different specificities of cellular binding proteins, such as CKIP-1, Hsp90, Pin-1, and PP2A (Olsten et al., 2005).
Despite the many isoforms of catalytic subunits, only one regulatory subunit has been identified for CK2β in mammals (Allende and Allende, 1995). In contrast to the activity of regulatory subunits of other kinases, such as PKA (cAMP-dependent protein kinase) and CDK (cyclin-dependent protein kinase), CK2β does not switch on or off the intrinsic activity of the catalytic subunits (Bolanos-Garcia et al., 2006).
The CK2β regulatory subunit is remarkably conserved among species, but it does not have homology with the regulatory subunits of other protein kinases (Bibby & Litchfield, 2005). The amino acid sequence of the CK2β regulatory subunit is almost identical in
Results presented by several groups and obtained by the use of a variety of approaches, including X-ray crystallography, have determined that a dimer of the CK2β subunits forms the core of the CK2 tetramer (Chantalat et al., 1999; Sarno et al., 2000; Canton et al., 2001).
The CK2β regulatory subunit is a compact, globular homodimer that shows high amino acid sequence conservation across species. The N-terminal domain (amino acids 1-104) is globular and contains four α-helices (marked as α1-α4 in Fig. 1). Helices α1 (residues 9–14), α2 (residues 27–31) and α3 (residues 46–54) wrap around α4 (residues 66–89) (Bolanos-Garcia et al., 2006). This part of the protein contains autophosphorylation sites, consisting of serines 2, 3, and possibly 4 (Boldyreff et al., 1993). Studies conducted by Zhang and coworkers (2002) indicate that phosphorylation of these sites enhances CK2β stability. The first 20 N-terminal amino acids of the CK2β regulatory subunit are also involved in the interaction with Nopp140, a protein that binds a nuclear localization sequence and shuttles between the nucleus and the cytoplasm (Li et al., 1997). This part of the protein also contains two motifs that have been previously characterized as motifs that regulate cyclin degradation. The CK2β regulatory subunit has a sequence resembling the nine-amino-acid motif called the destruction box, which plays a key role in the specific degradation of cyclin B at the end of mitosis (King et al., 1996). This motif, located in helix α3, contains three highly conserved residues that conform to the general destruction box consensus (RXXLXXXXN/D) (Bolanos-Garcia et al., 2006). Interestingly, this motif is located on a surface-exposed α3 helix, where it would be available for recognition by the cellular degradation machinery. A signal known as the KEN box, which was found previously in mitotic cyclins and which has been shown to play a role in mediating cell cycle-dependent protein degradation, is also present in CK2β. This degradation motif is characterized by the minimal consensus sequence KEN, but it is often followed shortly by either an N or D residue and is often preceded by another N or D residue. A similar sequence (D32KFNLTGLN40) forms helix α2 of the CK2β protein (Bibby & Litchfield, 2005).
The N-terminal part of the CK2β also contains an “acidic loop” between helices α3 and α4. This acidic, surface-exposed region of the protein, encoded by residues 55-64, has been identified as the site on CK2 that binds polyamines, which are known to stimulate CK2 activity
The analysis of the CK2β regulatory subunit structure by X-ray crystallography revealed the importance of the zinc finger in CK2β regulatory subunit dimerization (Chantal et al., 1999). The zinc-finger region is characterized by four conserved cysteine residues (residues 109, 114, 137 and 140), which mediate the interaction that allows the CK2β dimer to form the core of the CK2 holoenzyme (Chantal et al., 1999; Canton et al., 2001).
The C-terminal part of the CK2β regulatory subunit (residues 178–205) contains a large loop (residues 178–193) and helix α7 (residues 194–200). Although helix α7 is located away from helices α1-α6, the C-terminal amino acids (190-205) contribute to the formation of the CK2β regulatory subunit dimer (Niefind et al., 2001). This part of the regulatory subunit contains two phosphorylation sites: Thr213, which is phosphorylated by the checkpoint kinase Chk1 (Kristensen et al., 2004) and Ser209, which is phosphorylated
The traditional view of the CK2β regulatory subunit is that it functions as a component of tetrameric CK2 complexes and that it is the regulator of the catalytic CK2α and CK2α’ subunits, enhancing their stability, specificity and activity. As an example, the CK2β regulatory subunit stimulates CK2 holoenzyme activity towards certain protein substrates, such as topoisomerase II (Leroy et al., 1999), and inhibits others, like calmodulin (Marin et al., 1999).
It was shown that CK2β does not exist exclusively within stable CK2 complexes. This observation raises the prospect that CK2β has functions that are independent of its role as the regulatory subunit of CK2. For example, overexpression of CK2β in the fission yeast
CK2β seems to interact directly with more than 40 different proteins, including other protein kinases such as A-Raf, Chk1, Chk2, PKC-ζ, Mos and p90rsk (Bibby & Lichfield, 2005; Bolanos-Garcia et al., 2006; Olsen &Guerra, 2008). It was shown that association of the human protein kinases Chk1, Mos, and A-Raf is mediated by the C-terminal region of the CK2β subunit and that these associations involve some residues that interact with the catalytic CK2α subunit (Chen et al., 1997; Lieberman & Ruderman, 2004;Olsen & Guerra, 2008). The interaction between Chk1 and CK2β leads to an increase in the Cdc25C phosphorylation activity of Chk1. Screening of several cell lines has shown that the association between CK2β and Chk1 is also formed
Overexpression of CK2 has been linked to several pathological conditions, ranging from cardiovascular pathologies and cancer progression to neurodegenerative disorders (
2. Mutagenesis in studies on protein kinase CK2
Within the last 2 decades, a number of studies have produced mutants of both CK2α and CK2β that provide a valuable, yet incomplete, basis to rationalize the biochemical features of the enzyme, i.e., its constitutive activity, dual-cosubstrate specificity, acidophilic substrate specificity and tetrameric structure (Fig. 2).
2.1. Mutagenesis of the CK2α catalytic subunit
2.1.1. Mutations of CK2α in the regions responsible for constitutive activity
A majority of protein kinases need to be activated. Phosphorylation within the kinase activation loop is the most popular mode of activation. In contrast to other known protein kinases, CK2 has constitutive activity and does not demand activation. In this case, activation is achieved by the interaction between the N-terminal tail and the activation loop in the kinase domain. The role of the N-terminal segment in stable opening of the activation loop was confirmed in mutagenesis studies (Sarno et al., 2001). In particular, the Δ2-12 CK2α mutant, in comparison with the wild-type kinase, displayed an almost complete loss of activity, which was reflected by increased Km values for ATP and the peptide substrate (from 10 to 206 µM and from 26 to 140 µM, respectively). Further experiments revealed that holoenzyme reconstitution restored the activity of the mutant to the wild-type level. This demonstrates an alternative CK2β subunit-dependent mechanism to provide constitutive activity in the case of CK2 holoenzyme (Sarno et al., 2002).
Recently, molecular dynamics (MD) simulation has been carried out in order to explore the role of the CK2α N-terminal segment in the conformational behavior of the kinase (Cristiani
et al., 2011). Comparison of the αC-helix RMSD (root mean square deviation) values obtained for the Δ2-12 CK2α mutant (
The experiment presented above is an example of the validation of
2.1.2. Mutation of CK2α in the basic regions
Protein kinase CK2 is characterized by its special aptitude to interact with negatively charged ligands. This ability correlates with the presence of several basic residues in CK2α that are not conserved in a majority of other protein kinases. These residues are located mainly in the “Lys-rich segment” and in the “p+1 loop.” The Lys-rich segment (K74KKKIKR80) at the beginning of the αC-helix is a distinctive feature of CK2α (Tuazon & Traugh, 1991; Guerra et al., 1999). Results from mutational studies support the notion that this cluster is involved in substrate recognition, inhibition by heparin, down-regulation by the CK2β subunit and interaction with heat shock protein 90, and nuclear targeting (Guerra et al., 1999; Pinna & Meggio, 1997) (Table 1). CK2α mutants from
Extended mutagenesis analysis combined with biochemical characterization provided clear evidence that residues responsible for both substrate recognition and down-regulation of CK2α catalytic activity are located mainly in the Lys-rich loop and p+1 loop spanning sequences 74-83 and 191-198, respectively. This corroborates the concept that the CK2β subunit down-regulates the CK2β by acting as a pseudosubstrate (Meggio et al., 1994; Sarno et al., 1996, 1997a, 1999).
Sarno and collaborators (1997b) analyzed the relative contribution of basic residues, presumably implicated in CK2-substrate interaction, in the recognition of peptide substrates varying in the number and position of acidic determinants. Sixteen derivatives of the optimal peptide substrate RRRA-DDSDDDDD, wild-type CK2 and twelve CK2α mutants defective in substrate recognition were used in the experiments. In the CK2α mutants, different basic residues implicated in substrate recognition were replaced by alanine (
2.1.3. Mutations of CK2α in catalytic subdomains
Subdomains II and VII of CK2α involved in nucleotide binding and phosphotransfer are in close proximity to each other in the three-dimensional structure. CK2α differs from more than 95% of other known protein kinases in having Val66 instead of the corresponding alanine within conserved region II and Trp176 instead of the corresponding phenylalanine within region VII (Allende & Allende, 1995). To investigate whether these variant amino acid residues might be responsible for effective GTP utilization, Jakobi and Traugh (1995) mutated both of these residues back to the consensus amino acids. Their results indicated that both single mutants of CK2α and the double mutant CK2α could still use GTP as a phosphate donor. The single and double mutations only altered the relative affinities for ATP and GTP. This finding indicated that at least one other amino acid residue must be responsible for the effective utilization of GTP by CK2. The same authors studied the above-mentioned mutants with respect to the catalytic activity of the reconstructed holoenzyme. The relatively lower affinity for GTP of the holenzyme reconstructed from the mutated CK2α was caused by changes in both the
Srinivasan and collaborators (1999) showed that the dual specificity of CK2 probably originated from the loop situated around the stretch H115VNNTD120 in CKα. In their work, they combined site-directed mutagenesis of CK2α with comparative 3D-structure modeling. Due to significant amino acid sequence similarity (69,5%), kinase CDK2 was chosen to be a good comparative model for CK2α. Based on modeling, a ΔN118 CK2α mutant was constructed. The kinase assay showed decreased affinity of this protein to GTP, in comparison to the wild-type CK2α. The
The latter study was extended by Jakob and collaborators (2000), who created several mutants of
The mutagenesis by Yde and collaborators (2005) resulted in the first stable and fully active mutant of the human catalytic subunit of protein kinase CK2 that is devoid of dual cosubstrate specificity. The resulting mutant hsCK2α1-335 (human CK2 deleted for the last 56 amino acids) V66A/M163L was designed on the basis of several structures of the enzyme from
The mutagenesis studies also provided much insight into the significance of the sequence of the catalytic domain with respect to the CK2α/CK2β interaction
It is known that the hydrophobic and polar residues of domain II and VII are responsible for the selectivity of a number of specific, potent CK2 ATP-competitive inhibitors, like TBBz (tetrabromobenzimidazole) and TBBt (tetrabromobenzotriazole) (Sarno et al., 2005a). The importance of the same key residues in the hydrophobic portion of the binding site was corroborated by mutational analysis of residues of the human CK2α. Their side chains contribute to the reduction in the internal size of the hydrophobic pocket adjacent to the ATP/GTP-binding site in CK2 (Battistutta et al., 2001; Sarno et al, 2005). Three of these residues (Val66 or Ile66, Ile174, and Met163) are specific to CK2. They are generally replaced by smaller ones in other protein kinases. Both single and double mutants with substitutions for Val66 and Ile174 gave rise to catalytically active CK2α with altered susceptibility to various inhibitors. However, replacement of Met163 by glycine produced a catalytically inactive mutant (Sarno et al., 2005b). Similar data were obtained with yeast CK2α. Mutants with alterations to V67 and I213 (analogous to V66 and I174 of human CK2α) displayed considerably higher Ki values toward inhibitors TBBz and TBBt and only a slight change in the affinity for ATP (Sajnaga et al, 2008). The structural basis for decreased emodin binding to human CK2α resulting from a single point mutation (V66A) has been examined by molecular dynamics (MD) simulations and energy analysis (Zhang & Zhong, 2010). It was found that the V66A mutation resulted in a packing defect due to a change in hydrophobicity. It led to abnormal behavior of the glycine-rich loop, α-helix, and C-loop. The critical role of Ile66 in cosubstrate binding and selection, besides forcing the nucleotide ligands to adopt different positions in the binding pocket, was also demonstrated in a mutational study (Jakobi et al., 1994; Jakobi & Traugh, 1992, 1995).
Chaillot and collaborators (2000) studied the role of Gly177 in conserved region VII of the catalytic domain, which is close to the active site. It was revealed that the CK2α G177K mutant exhibited improved catalytic efficiency for acid peptidic substrates, probably by establishing interactions with the acidic residues.
The acidic residue Asp or Glu of the catalytic loop (corresponding to Glu170 in PKA and conserved in most Ser/Thr protein kinases) is responsible for the binding of basic residues that specify the protein/peptide substrates. In CK2, the residue is replaced by a histidine (His160). Such a substitution could explain the acidophilic properties of CK2, in contrast to the basophilic properties of PKA and other Ser/Thr kinases. The actual role of the His160 in the determination of the site specificity of CK2 was assessed by Dobrowolska and collaborators (1994). Interestingly, subsequent mutational studies in which His160 was replaced with alanine or aspartic acid ruled out any significant role of this residue in substrate recognition (Sarno et al., 1997b).
A CK2α inactive mutant (D156A) was produced based on structural homology to kinase PKA. The mutant protein was able to compete efficiently with the wild-type CK2α for the regulatory β subunits. Although it does not exhibit kinase activity, the D156A mutant can bind CK2β to form an inactive holoenzyme. Moreover, the mutant abolishes the inhibitory effect of CK2β on CK2α-mediated phosphorylation of calmodulin. These results suggest that CK2α D156A may be a useful dominant-negative mutant for elucidation of the cellular functions of the CK2 regulatory subunit (Cosmelli et al., 1997).
2.1.4. Mutations of CK2α in the glycine-rich loop
The glycine-rich sequence (G-loop) is one of the most critical structures of protein kinases, since it contributes in many ways to enzyme activity. This multifunctional structural element participates in nucleotide binding, substrate recognition, catalysis, and regulation of activity (Bossemeyer et al., 1994). In their extensive mutational studies combined with biochemical characterization, Sarno and collaborators (1999) confirmed that some basic residues in the glycine-rich loop of the CK2α, particularly Lys49, are implicated in substrate recognition and inhibition by polyanions. Another residue located within this region, Gly48, is involved in binding the ATP phosphate moiety. Replacement of Gly48 by alanine in CK2α affected its catalytic efficiency and specificity. It is thought that alanine causes this phenotype by creating an electrostatic barrier between ATP and the peptide substrate (Chaillot et al., 2000).
2.1.5. Mutations of CK2α in the C-terminal region
The C-terminal region of vertebrate CK2α is composed of 54 amino acids. Knowledge of this segment is rather poor, except for phosphorylation by kinase p34Cdc2 and interaction with isomerase Pin1 (Bosc et al., 1995; Messenger et al., 2002). It is known from the publications on crystallization of CK2 that the catalytic subunits are particularly sensitive to degradation, which makes the crystallization process of the entire subunit difficult (Niefind et al., 2000, 2001). Truncation at the C-terminus reduced the intrinsic degradability of CK2α and allowed its crystallization and the determination of its 3D structure. Starting from sequence alignments of C-termini from different CK2αs, Grasselli and collaborators (2004) constructed a mutant carrying the substitution of two distal prolines with alanines (P382A/P384A). Most intriguing was the resistance of the mutant to proteolytic degradation, which makes this protein an excellent candidate for crystallization of the entire CK2α subunit.
Bischoff and collaborators (2011) have recently determined for the first time the structure of the full-length human CK2α`C336S subunit. A point mutation of CK2α` was necessary to prevent covalent dimerization from intermolecular disulfide bridges formed by Cys336. However, these results shed light on the differences between the two catalytic subunits, α and α` (
2.1.6. Mutagenesis of CK2α in other regions
Determination of the structure of the CK2 holoenzyme and individual subunits provided knowledge about the nature and location of the interface between catalytic and regulatory subunits (Niefind et al., 2001). Using structure-guided alanine-scanning mutagenesis combined with isothermal titration calorimetry (ITC), energetic “hot spots” were identified on the surface of CK2α that determine the α/β subunit interaction (Raaf et al., 2011). Three single and one double CK2α subunit mutants were produced, in which individual hydrophobic amino acids located within the CK2α interface were replaced by alanine. The ITC analysis of CK2α mutants revealed that substitution of Leu41 and Phe54 were most disruptive to binding of CK2β. Moreover, the L41A and F54A mutants retained their kinase activity, compared to the wild-type CK2. Based on the results mentioned above, it can be claimed that these residues are suspected of being interaction “hot spots” (Raaf et al., 2011).
The amino-acid sequence and the structure of yeast protein kinase CK2α differ from those of CK2α’ and other eukaryotic CK2α subunits. CK2α is unique in containing a 38-amino-acid loop consisting of two α-helical structures situated close to structures engaged in ATP/GTP and substrate binding (Niefind et al., 2001). Modeling of the tertiary structure of the CK2α showed that, after removing both α-helical motifs, the CK2α subunit assumes a structure that is more similar to that of CK2α’ than it is to the structure of intact CK2α. The deletion of the 38 amino acids from CK2α drastically decreases its catalytic efficiency. Its characteristics are similar to yeast CK2α’ with respect to sensitivity to salt, heparin and spermine (Sajnaga et al., 2008) (Fig. 3).
K49 | Subd. I; Gly loop | K49A | Sarno et al., 1999 | |
K74 K75 K76 K77 | Subd. II/III, Lys rich loop | K74-77A, K77A | Sarno et al., 1997a, 1998, 1999, Vaglio et al. 1996 Gatica et al., 19941 | |
K79 R80 K83 | Subd. III, Helix C | K79A, R80A/K83A | Sarno et al., 1998, 1999 | |
K122 | Subd.V, Linker region | K122A | Sarno et al., 1997a, 1999 | |
H160 | Subd. VIb, Catalytic loop | H160D | Dobrowolska et al., 1994 | |
R191 R195 K190 K198 | Subd. VIII, p+1 loop | R191, 195, K190A K198A | Sarno et al., 1997a, 1998, 1999; Vaglio et al., 1996 | |
G482 | Subd. I, Gly loop | G48D | Chaillot et al., 2000 | |
V66 M163 | Subd. II Subd. VIb | V66A M163A CK2α 1-335 | Yde et al., 2005 | |
V66 I174 | Subd. II Subd. VII | V66A/I174A | Sarno et al., 2005 | |
V66/W176 | Subd. II, Subd. VII | V66A/W176F | Jakobi and Traugh, 1992, 1995 | |
N118 | Subd. V, ATP/GTP binding region | N118A, CK2αΔN118 | Srinivasan et al., 1999; Jakob et al., 2000 | |
D156 | Subd. VIb | D156A | Cosmelli et al., 1997 | |
M163 | Subd. VIb | M163G | Sarno et al., 2005 | |
G177 | Subd. VII | G117K | Chaillot et al., 2000 | |
N189 | Subd. VII, Activating segment | N189R | Srinivasan et al., 1999 | |
L41 | Subd. I | L41A | Raaf et al., 2011 | |
L54 | Subd. I, ATP/GTP binding region | L54A | Raaf et al., 2011 | |
V66 W176 | Subd. II Subd. VII | V66A, V66A/W176F | Sarno et al., 1997b Jakobi &Traugh, 1992 | |
M6 –V30 | N-terminus | Δ2-12, Δ2-18, Δ2-24, Δ2-30 | Sarno et al., 2001, 2002; Cristiani et al., 2011 | |
Y125 | Subd. V, Hinge region | Y125F4 | Cristiani et al., 2011 | |
E180 | Subd. VII, Activation segment | E180A | Sarno et al., 2002 | |
E182 | Subd. VII, Activation segment | Y182F | Sarno et al., 2002 | |
M336-Q393 | C-terminus | Δ336-393 | Ermakova et al., 2003 | |
P382 P384 | C-terminus | P382A P384A | Grasselini et al., 2004 | |
C3363 | C-terminus | C336S | Bischoff et al., 2011 |
The deletion of the loop of amino acids 91-128 from yeast CK2α led to behavioral and structural similarity to CK2α` (Sajnaga et al., 2008). The 3D models of proteins were created using the SWISS-MODEL software based on protein structure templates (PDB code 1ds5D) available in the Protein Data Bank and visualized with the PyMOL software.
Chimeras of different kinases can be easily engineered using recombinant DNA technology and used in studies on the structure and function of kinase. To study the effect of CK2β on the activity of CK1α, Jedlicki and collaborators (2008) generated CK2α/CK1α chimeras that were able to bind tightly to the CK2β regulatory subunit, but maintain the peptide substrate specificity of CK1. This is related to the capacity of the CK2β to regulate the activity of CK2α, as well as other protein kinases, such as A-Raf, C-Mos, and Chk1. It has been shown that a chimera combining a large part of the CK1α kinase with the N-terminal region of CK2α that is responsible for binding CK2β can be stimulated by this subunit. It is possible that such chimeras could be used to test the presence of “the docking site” on the CK2β subunit, which would bring substrate molecules near the catalytic subunits.
2.2. Mutagenesis of the regulatory subunit CK2β
From the primary sequence of the β subunit, it is obvious that the charged amino acids are not equally distributed. The acidic residues are clustered in the N-terminal half, whereas the basic residues are clustered in the C-terminal part of the molecule. Mutational studies have shown that, in contrast to cyclins, which invariably act as indispensable activators of CK2-related CDKs, the CK2β subunit fulfills antagonist functions. The features of CK2β can be explored by generating large synthetic fragments, some of which reproduce the C-terminal moiety and thus stimulate its catalytic activity. Fragments reproducing segments of the N-terminal sequence are inhibitory, which becomes especially evident when calmodulin is the substrate (Marin et al, 1992, 1995; Meggio et al, 1994; Sarno et al, 1997a).
2.2.1. Mutations of CK2β that affect autophosphorylation
The CK2β subunit is known to be autophosphorylated by the catalytic subunit. Autophosphorylation occurs on serine residues at positions 2 and 3 in the amino-terminal region of the molecule. Both these serines fit CK2 consensus specificity requirements (Marin et al, 1992). This finding was corroborated by the fact that the mutant S2,3G (
2.2.2. Mutations of CK2β that affect binding with CK2α
In order to shed light on the mechanisms by which the CK2β subunits affect the catalytic properties of CK2 and to elucidate the molecular interactions between the catalytic and regulatory subunits of CK2, Boldyreff and collaborators (1992, 1993) generated a number of mutants of the CK2β subunit, which were tested for their ability to functionally replace the wild-type CK2β. These authors showed that deletion of the last 44 residues of the C-end (CK2β Δ171-215) eliminated the capacity to form tetramers with CK2α and to stimulate activity. However, deletion of the last 34 amino acids (CK2βΔ181-215) yielded an active CK2β that had lower affinity for CK2α. Shorter deletions (
Mutagenesis along with crosslinking and peptide studies have shown that the acidic amino acid stretch of CK2β from residues 55-64 interacts with a corresponding basic stretch of the CK2α subunit. However, these weak electrostatic interactions seem to determine the activity of, but not the formation of, the CK2 holoenzyme (Krehan et al., 1996, Sarno et al, 1997b).
Kusk and collaborators (1995) used mutagenesis of CK2 subunits with a yeast two-hybrid system to explore domains involved in intersubunit contact. [In the yeast two-hybrid system, a peptide or protein is fused to part A of a transcriptional activator. Another peptide or protein is fused to part B. Transcriptional activation of an easily assayed reporter gene occurs only when part A and part B come together. Parts A and B themselves cannot interact to form the transcriptional activator, nor can either part individually (part A, the part A fusions, part B, and the part B fusions) cause the reporter to be expressed. However, if the fusions interact, part A and part B can come together, and the reporter is activated. This is an indication that the peptides or proteins in the fusions can interact.] A series of plasmid constructs was prepared. They encoded N-terminal or C-terminal truncations of the CK2α and CK2β subunits to indicate which regions of the subunits were engaged in CK2 holoenzyme formation in yeast cells. The data revealed that the regulatory CK2β subunit has a modular structure. An N-terminal domain (residues 20-145) is responsible for homodimerization (CK2β/CK2β). A C-terminal domain (residues 152-200) is necessary for heterodimerization (CK2α/CK2β). Amino acid residues 1 to 20 in the N-terminus and 351 to 391 in the C-terminus of CK2α are dispensable for interaction with the regulatory subunit.
2.2.3. Mutations of CK2β that affect the activity of CK2α
The modulation of CK2α subunit activity by CK2β has a stimulatory effect on most substrates. However, when calmodulin is used as the substrate, the CK2β subunit almost completely inhibits the activity of the catalytic subunit (Guerra et al., 1999). This inhibition can be overcome by addition of polylysine (Meggio et al, 1992). Mutagenesis studies on the CK2β subunit revealed an acidic stretch (amino acids 55-64) that is responsible for the inhibitory effect and for the stimulation by polylysine (Meggio et al., 1994). Interestingly, mutants of CK2β bearing substitutions at positions 55, 57, and 59-64 to alanine produced up to 4-fold more active holoenzyme after assembling with the catalytic α subunit than did the wild type. At the same time, these mutants were refractory to the stimulatory effect of polylysine. This finding revealed that the acidic N-terminal cluster of CK2β, especially Asp55 and Glu57, is involved in intrinsic down-regulation of CK2 basal activity and has been implicated in responsiveness to various effectors (Boldyreff et al., 1993, 1994).
Other data provided by Hinrichs and collaborators (1995) demonstrated that Pro58 located in the center of the acidic segment also constitutes an important structural feature affecting the function of down-regulation of CK2β towards the catalytic subunits. The effect of a mutation of proline to alanine resulted in an effect that was similar to mutation of the acidic residues alone. It produced hyperactive CK2β subunits that stimulated the CK2α activity to a greater extent than did the wild-type CK2β subunit.
2.2.4. Mutations of CK2β that affect export of the holoenzyme
It is known that protein kinase CK2 is present in not only the cytoplasm, nuclei, and several other cell organelles, but also on the external side of the cellular membrane (Kubler et al, 1983). Rodrigez and collaborators (2008) have studied the role of CK2β in the export of the holoenzyme to the extracellular membrane through deletion and point mutations. The region of CK2β between amino acids 20 and 33 was found to be necessary, but not sufficient, to allow the catalytic subunits to function as an ectokinase. An important function of this region is fulfilled by Phe21 and Phe22, which anchor the loop of the 20-33 sequence. Another key element of this region is constituted by the acidic residues in positions 26-28. They are exposed to the medium, free to interact with other proteins (Bolanos-Garcia et al, 2006).
2.2.5. Mutation of CK2β that affects its stability
Overexpression of CK2 catalytic subunits leads to increased cell proliferation and transformation, while overexpression of the regulatory CK2 subunit is associated with decreased proliferation in yeast and mammalian cells (Li et al., 1999; Lebrin et al., 2001; Vilk et al., 2001). Moreover, CK2β is physiologically expressed at a higher level than CK2α, and the excess of the regulatory subunit is rapidly ubiquitinated and degraded in a proteasome- dependent manner (Luscher & Litchfield, 1994; Zhang et al., 2002). To protect CKβ from the degradation machinery and to stabilize it, six surface-exposed lysine residues were mutated to arginine (French et al., 2007). The 6KR mutant functioned as normal CK2β, but it was not sensitive to proteasome inhibition. The physiological role of mutagenesis-mediated CK2β stabilization was also examined with the use of cell proliferation assays. A significant decrease in proliferation was observed in cells expressing the 6KR mutant when compared to wild-type CK2β. The authors suggest that the stabilized form of the CK2 regulatory subunits can be utilized to inhibit cell proliferation in cancer cells (French et al., 2007).
2.3. Mutagenesis of CK2 substrates
Protein kinase CK2 is a multi-substrate enzyme with a large number of cellular partners. In 2003, Meggio and Pinna updated the list of 307 CK2 substrates with 308 sites phosphorylated by CK2 (Meggio & Pinna, 2003). This number is now out-of-date, as novel CK2 protein substrates are discovered every year. A
Mdm2 is a cellular oncoprotein that down-regulates the growth suppressor protein p53 (Barak et al., 1992). Computer analysis of the amino acid sequence of Mdm2 revealed 19 putative CK2 phosphorylation sites. Three Mdm2 mutants with deletions at codons 1-114, 93-285, and 271-491 were produced to exclude sites that are not affected by CK2. The phoshorylation assays revealed that only the central part of Mdm2 is phosphorylated. Based on further detailed analysis of the remaining CK2 consensus sites, Ser269 was chosen to be the most promising. Using overlap extension PCR (see section 2.7 in the chapter by Sturtevant), the Mdm2 point mutant S269A was constructed and the relevant CK2 phosphorylation site was finally discovered (Götz et al., 1999).
In some protein substrates, putative CK2 phosphorylation sites are located close to one another, and thus several point mutants had to be produced to score them. The consensus sequence analysis of the N-terminal domain of the human transcription factor Tcf-4 indicated multiple sites that fit the motif for CK2 phosphorylation. No CK2-mediated phosphorylation was detected on the Tcf-4 fragments comprising amino acids 1-30 and 1-49. Thus, the best candidates for CK2-affected amino acids were the serine residues located in the Tcf-4 peptide T54NQDSSSDSEAERRP68. Three Tcf-4 mutants, one triple point mutant (S58A/S59A/S60A) and two single point mutants (S58E and S60E) were made to help indicate the phosphorylatable amino acid.
Sic1 is a yeast protein that specifically inhibits Clb/Cdk activity in the G1 phase, so that DNA replication is suppressed (Verma et al., 2001; Nash et al., 2001). Moreover, Sic1 undergoes multistep phosphorylation. Therefore, Sic1 phosphorylation occurs at several positions. One looks like the CK2 consensus site. CK2-mediated phosphorylation of Sic1 within the Q199ESEDEED sequence was confirmed both
The regulatory effect of CK2 activity on the Wnt signaling pathway is widely known (Pinna, 2002; Litchfield, 2003). Kinase phosphorylates and interacts with β-catenin and thus enhances the stability and transcriptional activity of β-catenin (Song et al, 2003; Seldin et al, 2005). The AKT/PKB kinase is also a well-known CK2 substrate and interacting partner. CK2-mediated phosphorylation at Ser129 causes AKT hyperactivation (Di Maira et al, 2005; Guerra, 2006). CK2 may link the two pathways..
To elucidate the roles of CK2 in the Wnt and AKT/PKB signaling pathways, the AKT phosphorylation-deficient mutant (S129A) was overexpressed in an embryonic cell line. The β-catenin-dependent transcriptional activity was analyzed. The data obtained indicate that blockage of AKT phosphorylation by CK2 impairs β-catenin activity and decreases its stability. Therefore, CK2-mediated AKT phosphorylation at Ser129 is a necessary step in the up-regulation of the β-catenin transcriptional activity in human embryonic kidney cells (Ponce et al., 2011).
Besides phosphorylation of numerous cellular proteins, CK2 directly interacts with many of them forming protein-protein complexes (Litchfield, 2003). Both catalytic and regulatory CK2 subunits can interact with different proteins, independently of the holoenzyme (Bibby et al., 2005). Wee1 kinase, involved in cell cycle progression, is one such CK2 protein partner. The Wee1 kinase is a key inhibitor of cyclin-dependent kinase (CDK1) and mitotic entry in eukaryotes. Several deletion mutants of the Wee1 catalytic domain were produced to investigate the interaction with CK2 subunits. Immunoprecipitation experiments revealed that Wee1 binds CK2β via two domains of Wee1 (comprising amino acids 59-71 and 232-332) and two regions of CK2β (comprising residues 1-5 and 155-170). Although the interaction does not affect Wee1 activity, it up-regulates CDK1 by reversing the Wee1-mediated inhibitory effect on CDK1. These findings reinforce the notion that CK2β can serve other protein kinases. It may be a universal regulatory subunit that can act independently of the CK2 holoenzyme (Olsen et al., 2010).
3. Conclusion
Even 58 years after its first description (Burnett & Kennedy, 1954), the story of protein kinase CK2 has not been fully clarified. This enzyme catalyzes phosphorylation of over 300 substrates. They are characterized by having multiple acidic residues surrounding the phospho-acceptor amino acid. Consequently, CK2 plays a key role in several physiological and pathological processes (Guerra & Issinger, 2008). After all those years of research, we are still asking the question: how is it possible that one kinase can be involved in so many different biochemical processes in the cell? Using different biochemical and genetic methods, we have solved several problems connected with the structure and mechanism of the catalytic action of this enigmatic protein kinase. The application of mutagenesis methods in many cases has helped us and will continue to help us get answers to many problems connected with CK2 activity. Among them are the following:
The interaction between subunits
Catalytic specificity and efficiency
Substrate recognition
Regulation by the β-subunit
Stability of the subunits
Interactions with modulators and substrates
The effect of phosphorylation on catalytic activity
Constitutive CK2 activity.
A protein kinase, such as CK2, is difficult to explore with respect to its physiological functions. CK2 has been shown to be involved in numerous aspects of cell proliferation and survival, including cell cycle progression and apoptosis control (Ahmad et al., 2008; Ahmed et al., 2002; Batistuta, 2009; Gyenis & Litchfield, 2008; Meggio & Pinna, 2003; Litchfield, 2003). Alterations in the levels or activity of CK2 have been implicated in a variety of human diseases, including cancers (Guerra & Issinger, 2008). All these observations raise important questions regarding the mechanisms that control CK2 activity and specificity. These questions have a special value, since defects in regulation of these processes could contribute to tumorigenesis.
In this context, the application of mutagenesis methods, together with other techniques (
Acknowledgement
The 3D protein structure models of CK2 were kindly constructed by Maciej Masłyk, PhD. (Department of Molecular Biology, Institute of Biotechnology, The John Paul II Catholic University of Lublin, Poland)
References
- 1.
Ahmad K. A Wang G Unger G Slaton J Ahmed K 2008 Protein kinase CK2- A key suppressor of apoptosis.48 1 April 2008),179 187 0065-2571 - 2.
Ahmed K Gerber D. A Cochet C 2002 Joining the cell survival squad: an emerging role for protein kinase CK2. Trends in Cellular Biology,12 5 May 2002),226 230 0962-8924 - 3.
Adler V Pincus M. R Minamoto T Fuchs S. Y Bluth M. J Brandt-rauf P. W Friedman F. K Robinson R. C Chen J. M Wang X. W Harris C. C Ronai Z 1997 Conformation-dependent phosphorylation of p53. ,94 5 March 1997),1686 1691 0027-8424 - 4.
Allende J. E Allende C. C 1995 Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. ,9 5 March 1995),313 323 0892-6638 - 5.
Arnold K Bordoli L Kopp J Schwede T 2006 The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.22 2 January 2006),195 201 1367-4803 - 6.
Barak Y Oren M 1992 Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest. ,11 6 June 1992),2115 2121 0261-4189 - 7.
Battistutta R 2009 Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.66 11-12 June 2009),1868 1889 0142-0682 X. - 8.
L.A. (Battistutta R Sarno S De Moliner E Marin O Issinger O G Zanotti G Pinna 2000 The crystal structure of the complex of alpha subunit with a fragment of human beta subunit provides the clue to the architecture of protein kinase CK2 holoenzyme. European Journal of Biochemistry 267,16 August 2000),5184 5190 0014-2956 - 9.
Battistutta R De Moliner E Sarno S Zanotti G Pinna L. A 2001 Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole. ,10 11 November 2001),2200 2206 0961-8368 - 10.
Bibby A. C Litchfield D. W 2005 The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta. ,1 2 April 2005),67 79 1449-2288 - 11.
K. (Bischoff N Olsen B Raaf J Bretner M Issinger O G Niefind 2011 Structure of the human protein kinase CK2 catalytic subunit CK2alpha’ and interaction thermodynamics with the regulatory subunit CK2beta. ,407 1 March 2011),1 12 1089-8638 - 12.
G. (Becker W Weber Y Wetzel K Eirmbter K Tejedor F. J Joost H 1998 Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. Journal of Biological Chemistry,273 40 October 1998),25893 25902 0021-9258 - 13.
andBiondi R. M Nebreda A. R 2003 Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.372 Pt. 1, (May 2003),1 13 0264-6021 - 14.
Bolanos-garcia V. M Fernandez-recio J Allende J. E Blundell T. L 2006 Identifying interaction motifs in CK2beta--a ubiquitous kinase regulatory subunit. ,31 12 December 2006),654 661 0968-0004 - 15.
G. (Boldyreff B Meggio F Pinna L. A Issinger O 1992 Casein kinase-2 structure-function relationship: creation of a set of mutants of the beta subunit that variably surrogate the wildtype beta subunit function. ,188 1 October 1992),228 234 0000-6291 X - 16.
G. (Boldyreff B Meggio F Pinna L. A Issinger O 1993 Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated beta-subunits. ,32 47 November 1993),12672 12677 0006-2960 - 17.
kinase CK2 structure-function relationship: effects of the beta subunit on reconstitution and activity. ,Boldyreff B Meggio F Pinna L. A Issinger O G 1994 Protein 40 5-6 January 1994),391 399 0968-8773 - 18.
is the autophosphorylation site in the beta subunit from bicistronically expressed human casein kinase-2 and from native rat liver casein kinase-2 beta.Boldyreff B James P Staudenmann W Issinger O G 1993 Ser 218 2 December 1),515 521 0014-2956 - 19.
G. (Boldyreff B Mietens U Issinger O 1996 Structure of protein kinase CK2: dimerization of the human beta-subunit. ,379 2 January 1996),153 156 0014-5793 - 20.
Brognard J Hunter T 2011 Protein kinase signaling networks in cancer.21 1 February 2011),4 11 0095-9437 X. - 21.
Phosphorylation of casein kinase II by p34cdc2. Identification of phosphorylation sites using phosphorylation site mutants in vitro. ,Bosc D. G Slominski E Sichler C Litchfield D. W 270 43 October1995 25872 25878 0021-9258 - 22.
Bossemeyer D 1994 The glycine-rich sequence of protein kinases: a multifunctional element. ,19 5 May 1994),201 205 0968-0004 - 23.
Burnett G Kennedy E. P 1954 The enzymatic phosphorylation of proteins.,211 2 December 1954),969 980 0021-9258 - 24.
Canton D. A Zhang C Litchfield D. W 2001 Assembly of protein kinase CK2: investigation of complex formation between catalytic and regulatory subunits using a zinc-finger-deficient mutant of CK2beta. ,358 Pt. 1, (August 2001),87 94 0264-6021 - 25.
Chantalat L Leroy D Filhol O Nueda A Benitez M. J Chambaz E. M Cochet C Dideberg O 1999 Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization. EMBO Journal,18 11 June 1999),2930 2940 0261-4189 - 26.
Chaillot D Declerck N Niefind K Schomburg D Chardot T Meunier J. C 2000 Mutation of recombinant catalytic subunit alpha of the protein kinase CK2 that affects catalytic efficiency and specificity. ,13 4 April 2000),291 298 0269-2139 - 27.
Chen M Li D Krebs E. G Cooper J. A 1997 The casein kinase II beta subunit binds to Mos and inhibits Mos activity.,17 4 April 1997),1904 1912 0270-7306 - 28.
di Fonzo, A., Magni, F., Vanoni, M. & Alberghina, L. (Coccetti P Rossi R. L Sternieri F Porro D Russo G. L 2004 Mutations of the CK2 phosphorylation site of Sic1 affect cell size and S-Cdk kinase activity in Saccharomyces cerevisiae. ,51 2 January 2004),447 460 0095-0382 X. - 29.
Coccetti P Zinzalla V Tedeschi G Russo G. L Fantinato S Marin O Pinna L. A Vanoni M Alberghina L 2006 Sic1 is phosphorylated by CK2 on Ser201 in budding yeast cells. ,346 3 August 2006),786 793 0000-6291 X. - 30.
Cohen P 2002 Protein kinases- the major drug targets of the twenty-first century? ,1 4 April 2002),309 315 1474-1776 - 31.
Cosmelli D Antonelli M Allende C. C Allende J. E 1997 An inactive mutant of the alpha subunit of protein kinase CK2 that traps the regulatory CK2beta subunit. ,410 2-3 June 1997),391 396 0014-5793 - 32.
Cristiani A Costa G Cozza G Meggio F Scapozza L Moro S 2011 The role of the N-terminal domain in the regulation of the "constitutively active" conformation of protein kinase CK2alpha: insight from a molecular dynamics investigation. ,6 7 July 2011),1207 1216 1860-7187 - 33.
Di Maira G., Salvi, M., Arrigoni, G., Marin, O., Sarno, S., Brustolon, F., Pinna, L. A. & Ruzzene, M. (2005 Protein kinase CK2 phosphorylates and upregulates Akt/PKB. ,12 6 June 2005),668 677 1350-9047 - 34.
Dobrowolska G Meggio F Marin O Lozeman F. J Li D Pinna L. A Krebs E. G 1994 Substrate recognition by casein kinase-II: the role of histidine-160. ,355 3 December 1994),237 241 0014-5793 - 35.
Duncan J. S Litchfield D. W 2008 Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.1784 1 January 2008),33 47 0006-3002 - 36.
Duncan J. S Turowec J. P Vilk G Li S. S. C Gloor G. B Litchfield D. W 2010 Regulation of cell proliferation and survival: Convergence of protein kinases and caspases.1804 3 March 2010)505 510 0006-3002 - 37.
Ermakova I Boldyreff B Issinger O. G Niefind K 2003 Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. ,330 5 July 2003),925 934 0022-2836 - 38.
Faust M Montenarh M 2000 Subcellular localization of protein kinase CK2. A key to its function? Cell and Tissue Research,301 3 September 2000),329 340 0030-2766 X. - 39.
French A. C Luscher B Litchfield D. W 2007 Development of a stabilized form of the regulatory CK2beta subunit that inhibits cell proliferation. ,282 40 October 2007),29667 29677 0021-9258 - 40.
Gatica M Jedlicki A Allende C. C Allende J. E 1994 Activity of the E75E76 mutant of the alpha subunit of casein kinase II from Xenopus laevis. ,339 1-2 February 1994),93 96 0014-5793 - 41.
Ghosh & Adams ( ,2011 Phosphorylation mechanism and structure of serine-arginine protein kinases278 4 February 2011),587 597 0000-1742 - 42.
Gianoncelli A Cozza G Orzeszko A Meggio F Kazimierczuk Z Pinna L. A 2009 Tetraiodobenzimidazoles are potnt inhibitors of protein kinase CK2. ,17 20 October 2009),7281 7289 0968-0896 - 43.
Gietz R. D andGraham K. C Litchfield D. W 1995 Interactions between the subunits of casein kinase II. ,270 22 June 1995),13017 13021 0021-9258 - 44.
Glover C. V 1998 On the physiological role of casein kinase II in . Progress in Nucleic Acid Research & Molecular Biology,59 May 1998),95 133 0079-6603 - 45.
Gotz C Kartarius S Scholtes P Nastainczyk W Montenarh M 1999 Identification of a CK2 phosphorylation site in mdm2. ,266 2 December 1999),493 501 0014-2956 - 46.
Gotz C Scholtes P Prowald A Schuster N Nastainczyk W Montenarh M 1999 Protein kinase CK2 interacts with a multi-protein binding domain of p53. ,191 1-2 January 1999),111 120 0300-8177 - 47.
andGraham K. C Litchfield D. W 2000 The regulatory beta subunit of protein kinase CK2 mediates formation of tetrameric CK2 complexes. J. Biol. Chem.275 5003 5010 - 48.
Grasselli E Tomati V Bernasconi M. V Nicolini C Vergani L 2004 C-terminal region of protein kinase CK2 alpha: How the structure can affect function and stability of the catalytic subunit. ,92 2 May 2004),270 284 0730-2312 - 49.
Guerra B 2006 Protein kinase CK2 subunits are positive regulators of AKT kinase. ,28 3 March 2006),685 693 1019-6439 - 50.
kinase CK2 in human diseases. ,Guerra B Issinger O G 2008 Protein 15 19 1870 1886 0929-8673 - 51.
J.Y. (Guerra B Issinger O G Wang 2003 Modulation of human checkpoint kinase Chk1 by the regulatory beta-subunit of protein kinase CK2. ,22 32 August 7),4933 4942 0950-9232 - 52.
Guerra B Boldyreff B Sarno S Cesaro L Issinger O. G Pinna L. A 1999 CK2: a protein kinase in need of control. ,82 2-3 May-June 1999),303 313 0163-7258 - 53.
Gyenis L Litchfield D. W 2008 The emerging CK2 interactome: insights into the regulation and functions of CK2. ,316 1-2 September 2008),5 14 0300-8177 - 54.
Hanks S. K Hunter T 1995 Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. ,9 8 May 1995),576 596 0892-6638 - 55.
Hanks S. K Quinn A. M Hunter T 1988 The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. ,241 4861 July 1),42 52 0036-8075 - 56.
Hinrichs M. V Jedlicki A Tellez R Pongor S Gatica M Allende C. C Allende J. E 1993 Activity of recombinant alpha and beta subunits of casein kinase II from Xenopus laevis. ,32 28 July 1993),7310 7316 0006-2960 - 57.
Hinrichs M. V Gatica M Allende C. C Allende J. E 1995 Site-directed mutants of the beta subunit of protein kinase CK2 demonstrate the important role of Pro-58. ,368 2 July 1995),211 214 0014-5793 - 58.
Hu E Rubin C. S 1990 Expression of wild-type and mutated forms of the catalytic (alpha) subunit of Caenorhabditis elegans casein kinase II in Escherichia coli. ,,265 33 November 1990),20609 20615 0021-9258 - 59.
G. (Issinger O 1993 Casein kinases: pleiotropic mediators of cellular regulation. ,59 1 January 1993),1 30 0163-7258 - 60.
Jacob G Neckelman G Jimenez M Allende C. C Allende J. E 2000 Involvement of asparagine 118 in the nucleotide specificity of the catalytic subunit of protein kinase CK2. ,466 2-3 January 2000),363 366 0014-5793 - 61.
Jakobi R Traugh J. A 1992 Characterization of the phosphotransferase domain of casein kinase II by site-directed mutagenesis and expression in Escherichia coli. ,267 33 November 1992),23894 23902 0021-9258 - 62.
Jakobi R Lin W. J Traugh J. A 1994 Modes of regulation of casein kinase II. ,40 5-6 421 429 0968-8773 - 63.
Jakobi R Traugh J. A 1995 Site-directed mutagenesis and structure/function studies of casein kinase II correlate stimulation of activity by the beta subunit with changes in conformation and ATP/GTP utilization. ,230 3 June 1995),1111 1117 0014-2956 - 64.
Janeczko M Masłyk M Szyszka R Baier A 2011 Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors. ,356 1-2 October 2011),121 126 0300-8177 - 65.
Jauch E Melzig J Brkulj M Raabe T 2002 functional analysis of Drosophila protein kinase casein kinase 2 (CK2) beta-subunit. Gene,298 1 September 18),29 39 0378-1119 - 66.
CK1alpha chimeras are sensitive to regulation by the CK2beta subunit. ,Jedlicki A Allende C. C Allende J. E 2008 C. K Alpha 316 1-2 September 2008),25 35 0300-8177 - 67.
Jensen B. C Kifer C. T Brekken D. L Randall A. C Wang Q Drees B. L Parsons M 2007 Characterization of protein kinase CK2 from . Molecular & Biochemical Parasitology,151 1 January 2007),28 40 0166-6851 - 68.
Johnson S. N 2009 Protein kinase inhibitors: contributions from structure to clinical compounds. ,42 1 February 2009),1 40 0033-5835 - 69.
King R. W Glotzer M Kirschner M. W 1996 Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. ,7 9 September 1996),1343 1357 1939-4586 - 70.
Ten Eyk, L.F., Ashford, V.A., Xuong, N.H., Taylor, S.S., Sowadski, J.M. (Knighton D. R Zheng J. H 1991 Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. ,253 5018 July 1991),407 414 0036-8075 - 71.
of a CK2α subunit and the holoenzyme from the mussel and construction of the CK2α and CK2β cDNAs. Marine Biotechnology (New York),Kolaiti R M Baier A Szyszka R Kouyanou-koutsoukou S 2011 Isolation 13 3 June 2011),505 516 1436-2228 - 72.
Kopp J Schwede T 2004 Automated protein structure homology modeling: a progress report. ,5 4 June 2004),405 416 1462-2416 - 73.
and purification of protein kinase CK2 recombinant alpha and beta subunits from the Mediterranean fly . Molecular and Cellular Biochemistry,Kouyanou-koutsoukou S Baier A Kolaitis R M Maniatopoulou E Thanopoulou K Szyszka R. ( 2011a Cloning 356 1-2 October 2011),261 267 0300-8177 - 74.
R. (Kouyanou-koutsoukou S Kalpaxis D. L Pytharopoulou S Kolaitis R M Baier A andSzyszka 2011b Translational control of gene expression in the mussel : The impact of cellular stress on protein synthesis, the ribosomal stalk and the protein kinase CK2 activity. In: Mussels: Anatomy, Habitat and Environmental Impact. (Ed. Lauren E. McGevin), Nova Publisher,97 128 978-1-61761-763-8 - 75.
Krehan A Lorenz P Plana-coll M Pyerin W 1996 Interaction sites between catalytic and regulatory subunits in human protein kinase CK2 holoenzymes as indicated by chemical cross-linking and immunological investigations. ,35 15 April 1996),4966 4975 0006-2960 - 76.
B. (Kristensen L. P Larsen M. R Hojrup P Issinger O G Guerra 2004 Phosphorylation of the regulatory β-subunit of protein kinase CK2 by checkpoint kinase Chk1: identification of the CK2β phosphorylation site. FEBS Letters,569 1-3 July 2004),217 223 0014-5793 - 77.
: a database of protein kinases in genomes. Nucleic Acids Research, Vol. 32 (Database Issue), (January 2004), pp. D153-D155, ISSN 0305-1048. .,Krupa ,A .,Abhinandan ,K.R . (2004)Srinivasan ,N Kin G - 78.
Kubiński K Domańska K Sajnaga E Mazur E Zieliński R Szyszka R 2007 Yeast holoenzyme of protein kinase CK2 requires both β and β’ regulatory subunits for its activity. ,295 1-2 January 2007),229 235 0300-8177 - 79.
Kubler D Pyerin W Burow E Kinzel V 1983 Substrate-effected release of surface-located protein kinase from intact cells. ,80 13 July 1983),4021 4025 0027-8424 - 80.
Kusk M Bendixen C Duno M Westergaard O Thomsen B 1995 Genetic dissection of intersubunit contacts within human protein kinase CK2. ,253 5 November 1995),703 711 0022-2836 - 81.
Lebrin F Chambaz E. M Bianchini L 2001 A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha. ,20 16 April 2001),2010 2022 0950-9232 - 82.
Leroy D Alghisi G. C Roberts E Filhol-cochet O Gasser S. M 1999 Mutations in the C-terminal domain of topoisomerase II affect meiotic function and interaction with the casein kinase 2 beta subunit. ,191 1-2 January 1999),85 95 0300-8177 - 83.
Leroy D Heriche J. K Filhol O Chambaz E. M Cochet C 1997 Binding of polyamines to an autonomous domain of the regulatory subunit of protein kinase CK2 induces a conformational change in the holoenzyme. A proposed role for the kinase stimulation.272 33 August 1997),20820 20827 0021-9258 - 84.
Li D Dobrowolska G Aicher L. D Chen M Wright J. H Drueckes P Dunphy E. L Munar E. S Krebs E. G 1999 Expression of the casein kinase 2 subunits in Chinese hamster ovary and 3T3 L1 cells provides information on the role of the enzyme in cell proliferation and the cell cycle. ,274 46 November 1999),32988 32996 0021-9258 - 85.
Li D Meier U. T Dobrowolska G Krebs E. G 1997 Specific interaction between casein kinase 2 and the nucleolar protein Nopp140. ,272 6 February 1997),3773 3779 0021-9258 - 86.
which inhibits Mos function, binds to a discrete domain in the N-terminus of Mos. ,Lieberman S. L Ruderman J. V 2004 C. K Beta 268 2 April 2004),271 279 0012-1606 - 87.
Liolli G 2010 Structural dissection of cyclin dependent kinases regulation and protein recognition properties. ,9 8 April 2010),1551 1561 1538-4101 - 88.
Litchfield D. W 2003 Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. ,369 Pt 1, (January 2003),1 15 0264-6021 - 89.
Litchfield D. W Bosc D. G Slonimski E 1995 The protein kinase from mitotic human cells that phosphorylates Ser-209 on the casein kinase II beta-subunit is p34cdc2. ,1269 1 October 1995),69 78 0006-3002 - 90.
Litchfield D. W Lozeman F. J Piening C Sommercorn J Takio K Walsh K. A Krebs E. G 1990 Subunit structure of casein kinase II from bovine testis: demonstration that the α and α´ subunits are distinct polypeptides. ,265 13 May 1990),7638 7644 0021-9258 - 91.
Luscher B Litchfield D. W 1994 Biosynthesis of casein kinase II in lymphoid cell lines. ,220 2 March 1994),521 526 0014-2956 - 92.
Manning G Plowman G. D Hunter T Sudarsanam S 2002a Evolution of protein kinase signaling from yeast to man. ,27 10 October 2002),514 520 0968-0004 - 93.
Manning G Whyte D. B Martinez R Hunter T Sudarsanam S 2002b The protein kinase complement of the human genome. ,298 5600 December 2002),1912 1934 0036-8075 - 94.
Maridor G Park W Krek W Nigg E. A 1991 Casein kinase II. cDNA sequences, developmental expression and tissue distribution of mRNAs for a, a´ and b subunits of the chicken enzyme. ,266 4 February 1991),2362 2368 0021-9258 - 95.
Marin O Meggio F Pinna L. A 1999 Structural features underlying the unusual mode of calmodulin phosphorylation by protein kinase CK2: A study with synthetic calmodulin fragments. ,256 2 March 1999),442 446 0000-6291 X. - 96.
Miranda-saavedra D Barton G. J 2007 Classification and functional annotation of eukaryotic protein kinases. ,68 4 September 2007),893 914 0887-3585 - 97.
Marin O Meggio F Draetta G Pinna L. A 1992 The consensus sequences for cdc2 kinase and for casein kinase-2 are mutually incompatible. A study with peptides derived from the beta-subunit of casein kinase-2. ,301 1 April 1992),111 114 0014-5793 - 98.
Marin O Meggio F Boldyreff B Issinger O. G Pinna L. A 1995 Dissection of the dual function of the beta-subunit of protein kinase CK2 (’casein kinase-2’): a synthetic peptide reproducing the carboxyl-terminal domain mimicks the positive but not the negative effects of the whole protein. ,363 1-2 April 1995),111 114 0014-5793 - 99.
Marin O Meggio F Sarno S Pinna L. A 1997 Physical dissection of the structural elements responsible for regulatory properties and intersubunit interactions of protein kinase CK2 beta-subunit. ,36 23 June 1997),7192 7198 0006-2960 - 100.
Meggio F Boldyreff B Marin O Marchiori F Perich J. W Issinger O. G Pinna L. A 1992 The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme.205 3 May 1992),939 945 0014-2956 - 101.
Meggio F Boldyreff B Issinger O. G Pinna L. A 1993 The autophosphorylation and p34cdc2 phosphorylation sites of casein kinase-2 beta-subunit are not essential for reconstituting the fully-active heterotetrameric holoenzyme. ,1164 2 July 1993),223 225 0006-3002 - 102.
Meggio F Boldyreff B Issinger O. G Pinna L. A 1994 Casein kinase 2 down-regulation and activation by polybasic peptides are mediated by acidic residues in the 55-64 region of the beta-subunit. A study with calmodulin as phosphorylatable substrate. ,33 14 April 1994),4336 4342 0006-2960 - 103.
Meggio F Pinna L. A 2003 One-thousand-and-one substrates of protein kinase CK2? ,17 3 March 2003),349 368 1530-6860 - 104.
Messenger M. M Saulnier R. B Gilchrist A. D Diamond P Gorbsky G. J Litchfield D. W 2002 Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions. ,277 25 June 2002),23054 23064 0021-9258 - 105.
Miller S. J Lou D. Y Seldin D. C Lane W. S Neel B. G 2002 Direct identification of PTEN phosphorylation sites. ,528 1-3 September 2002),145 153 0014-5793 - 106.
Garcia de Herreros, A. & Dunach, M. (Miravet S Piedra J Miro F Itarte E 2002 The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. ,277 3 January 2002),1884 1891 0021-9258 - 107.
Nash P Tang X Orlicky S Chen Q Gertler F. B Mendenhall M. D Sicheri F Pawson T Tyers M 2001 Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. ,414 6863 November 2001),514 521 0028-0836 - 108.
and preliminary characterization of crystals of human protein kinase CK2. ,Niefind K Guerra B Ermakowa I Issinger O G 2000 Crystallization 56 No. Pt 12, (December 2000),1680 1684 0907-4449 - 109.
G. (Niefind K Guerra B Ermakowa I Issinger O 2001 Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. ,20 19 October 2001),5320 5331 0261-4189 - 110.
Niefind K Issinger O. G 2010 Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design. ,1804 3 March 2010),484 492 0006-3002 - 111.
kinase CK2 in health and disease: Protein kinase CK2: from structures to insights. ,Niefind K Raaf J Issinger O G 2009 Protein 66 11-12 June 2009),1800 1816 0142-0682 X. - 112.
Olsen B. B Guerra B Niefind K Issinger O. G 2010 Structural basis of the constitutive activity of protein kinase CK2. ,484 No.515 529 1557-7988 - 113.
Olsen B. B Guerra B 2008 Ability of CK2β to selectively regulate cellular protein kinases. ,316 1-2 September 2008),115 126 0300-8177 - 114.
Olsten M. E Litchfield D. W 2004 Order or chaos? An evaluation of the regulation of protein kinase CK2. ,82 6 December 2004),681 693 0829-8211 - 115.
Olsten M. E Weber J. E Litchfield D. W 2005 CK2 interacting proteins: emerging paradigms for CK2 regulation? ,274 1-2 June 2005),115 124 0300-8177 - 116.
Di Maria, G., Elliott, M., Orzeszko, A., Cozza, G., Meggio, F. & Pinna, L.A. (Pagano M. O Bain J Kazimierczuk Z Sarno S Ruzzene M 2008 The selectivity of inhibitors of protein kinase CK2: an update. ,415 3 November 2008),353 365 0264-6021 - 117.
Pandit S. B Balaji S Srinivasan N 2004 Structural and functional characterization of gene products encoded in the human genome by homology detection. ,56 6 June 2004),317 331 1521-6543 - 118.
Pearson M. A Fabbro D 2004 Targetting protein kinases in cancer therapy: a success? ,4 6 December 2004),1113 1124 1473-7140 - 119.
Pinna L. A 2002 Protein kinase CK2: a challenge to canons. ,115 Pt. 20, (October 2002),3873 3878 0021-9533 - 120.
Pinna L. A Meggio F 1997 Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation. ,3 No.77 97 1087-2957 - 121.
Plowman G. D Sudarsanam S Bingham J Whyte D Hunter T 1999 The protein kinases of , a model for signal transduction in multicellular organisms. Proceedings of the National Academy of Sciences of the United States of America,96 24 November 1999),13603 13610 0027-8424 - 122.
Ponce D Maturana J. L Cabello P Yefi R Niechi I Silva E Armisen R Galindo M Antonelli M Tapia J. C 2011 Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of beta-catenin transcriptional activity. ,226 7 July 2010),1953 1959 1097-4652 - 123.
Prudent R Sautel C. F Cochet C 2010 Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2. ,1804 3 March 2010),493 498 0006-3002 - 124.
alpha and CK2beta, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2alpha surface. ,Raaf J Bischoff N Klopffleisch K Brunstein E Olsen B. B Vilk G Litchfield D. W Issinger O G Niefind K 2011 Interaction Between C. K 50 4 February 2011),512 522 1520-4995 - 125.
K. (Raaf J Brunstein E Issinger O G Niefind 2008 The interaction of CK2alpha and CK2beta, the subunits of protein kinase CK2, requires CK2beta in a preformed conformation and is enthalpically driven. ,17 12 December 2008),2180 2186 0961-8368 - 126.
Riera M Peracchia G De Nadal E Arino J Pages M 2001 Maize protein kinase CK2: regulation and functionality of three beta regulatory subunits. Plant Journal,25 4 February 2001),365 374 0960-7412 - 127.
Rodriguez F. A Contreras C Bolanos-garcia V Allende J. E 2008 Protein kinase CK2 as an ectokinase: the role of the regulatory CK2beta subunit. ,105 15 April 2008),5693 5698 1091-6490 - 128.
Roussou I Draetta G 1994 The casein kinase II alpha and beta subunits: evolutionary conservation and positive role of the beta subunit. Molecular and Cellular Biology,14 1 January 1994),576 586 0270-7306 - 129.
Sajnaga E Kubiński K Szyszka R 2008 Catalytic activity of mutants of yeast protein kinase CK2alpha. ,55 4 November 2008),767 776 0000-1527 X. - 130.
Salamon J. A Acuna R Dawe A. L 2010 Phosphorylation of phosducin-like protein BDM-1 by protein kinase 2 (CK2) is required for virulence and G beta subunit stability in the fungal plant pathogen Cryphonectria parasitica. ,76 4 May 2010),848 860 1365-2958 - 131.
L. A. (Sarno S Boldyreff B Marin O Guerra B Meggio F Issinger O G Pinna 1995 Mapping the residues of protein kinase CK2 implicated in substrate recognition: mutagenesis of conserved basic residues in the alpha-subunit. ,206 1 January 1995),171 179 0000-6291 X - 132.
Sarno S Ghisellini P Cesaro L Battistutta R Pinna L. A 2001 Generation of mutants of CK2alpha which are dependent on the beta-subunit for catalytic activity. ,227 1-2 November 2001),13 19 0300-8177 - 133.
Sarno S Ghisellini P Pinna L. A 2002 Unique activation mechanism of protein kinase CK2. The N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzyme. ,277 25 June 2002),22509 22514 0021-9258 - 134.
Sarno S Marin O Boschetti M Pagano M. A Meggio F Pinna L. A 2000 Cooperative modulation of protein kinase CK2 by separate domains of its regulatory beta-subunit. ,39 40 October 10),12324 12329 0006-2960 - 135.
Di Maira, G., Lucchini, V. & Pinna, L. A. (Sarno S Ruzzene M Frascella P Pagano M. A Meggio F Zambon A Mazzorana M 2005 Development and exploitation of CK2 inhibitors. ,274 1-2 June 2005),69 76 0300-8177 - 136.
Sarno S Salvi M Battistutta R Zanotti G Pinna L. A 2005 Features and potentials of ATP-site directed CK2 inhibitors. ,1754 1-2 December 2005),263 270 0006-3002 - 137.
Sarno S Vaglio P Cesaro L Marin O Pinna L. A 1999 A multifunctional network of basic residues confers unique properties to protein kinase CK2. ,191 1-2 January 1999),13 19 0300-8177 - 138.
L.A. (Sarno S Vaglio P Marin O Meggio F Issinger O G Pinna 1997a Basic residues in the 74-83 and 191-198 segments of protein kinase CK2 catalytic subunit are implicated in negative but not in positive regulation by the beta-subunit. ,248 2 September 1997),290 295 0014-2956 - 139.
Sarno S Vaglio P Marin O Issinger O. G Ruffato K Pinna L. A 1997b Mutational analysis of residues implicated in the interaction between protein kinase CK2 and peptide substrates. ,36 39 September 1997),11717 11724 0006-2960 - 140.
Sarno S Vaglio P Meggio F Issinger O. G Pinna L. A 1996 Protein kinase CK2 mutants defective in substrate recognition. Purification and kinetic analysis. ,271 18 May 1996),10595 10601 0021-9258 - 141.
a positive regulator of Wnt signalling and tumourigenesis. ,Seldin D. C Landesman-bollag E Farago M Currier N Lou D Dominguez I 2005 C. K As 274 1-2 June 2005),63 67 0300-8177 - 142.
Shi X Potvin B Huang T Hilgard P Spray D. C Suadicani S. O Wolkoff A. W andStanley P Stockert R. J 2001 A novel casein kinase 2 alpha-subunit regulates membrane protein traffic in the human hepatoma cell line HuH-7. ,276 3 January 2001),2075 2082 0021-9258 - 143.
Song D. H Dominguez I Mizuno J Kaut M Mohr S. C Seldin D. C 2003 CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. ,278 26 June 2003),24018 24025 0021-9258 - 144.
Srinivasan N Antonelli M Jacob G Korn I Romero F Jedlicki A Dhanaraj V Sayed M. F Blundell T. L Allende C. C Allende J. E 1999 Structural interpretation of site-directed mutagenesis and specificity of the catalytic subunit of protein kinase CK2 using comparative modelling. ,12 2 February 1999),119 127 0269-2139 - 145.
St-denis N. A Derksen D. R Litchfield D. W 2009 Evidence for regulation of mitotic progression through temporal phosphorylation and dephosphorylation of CK2alpha. ,29 8 April),2068 2081 0270-7306 - 146.
Trembley J. H Wang G Unger G Slaton J Ahmed K 2009 CK2: a key player in cancer biology. ,66 11-12 June 2009),1858 1867 0142-0682 X. - 147.
Tuazon P. T Traugh J. A 1991 Casein kinase I and II--multipotential serine protein kinases: structure, function, and regulation. ,23 No. (January 1991),123 164 1040-7952 - 148.
Vaglio P Sarno S Marin O Meggio F Issinger O. G Pinna L. A 1996 Mapping the residues of protein kinase CK2 alpha subunit responsible for responsiveness to polyanionic inhibitors. ,380 1-2 February 1996),25 28 0014-5793 - 149.
rd & Deshaies, R. J. (Verma R Mcdonald H Yates J. R 2001 Selective degradation of ubiquitinated Sic1 by purified 26S proteasome yields active S phase cyclin-Cdk. ,8 2 August 2001),439 448 1097-2765 - 150.
Vilk G Derksen D. R Litchfield D. W 2001 Inducible expression of the regulatory protein kinase CK2beta subunit: incorporation into complexes with catalytic CK2 subunits and re-examination of the effects of CK2beta on cell proliferation. ,84 1 84 99 0730-2312 - 151.
Vilk G Weber J. E Turowiec J. P Duncan J. S Wu C Derksen D. R Zień P Sarno S Donella-deana A Lajoie G Pinna L. A andLi S. S Litchfield D. W 2008 Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.20 11 November 2008),1942 1951 0898-6568 - 152.
Wirkner U Voss H Lichter P Pyerin W 1994 Human protein kinase CK2 genes. ,40 5-6 489 499 0968-8773 - 153.
Yde C. W Ermakova I Issinger O. G Niefind K 2005 Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate. ,347 2 March 2005),399 414 0022-2836 - 154.
Zhang C Vilk G Canton D. A Litchfield D. W 2002 Phosphorylation regulates the stability of the regulatory CK2beta subunit. ,21 23 May 2002),3754 3764 0950-9232 - 155.
Zhang N Zhong R 2010 Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2 alpha as determined by molecular dynamics. ,16 4 April 2010),771 780 0948-5023 - 156.
Zhang Y Dong C 2007 Regulatory mechanisms of mitogen-activated kinase signaling. ,64 21 November 2007),2771 2789 0142-0682 X.